Heterozygous Factor V Leiden deficiency with hepatic thrombosis in a twin pregnancy: a near missHepatic VeinsPregnancy, MultipleAdultFactor VFactor V DeficiencyFemaleHeterozygoteHumanPregnancyPregnancy Complications, CardiovascularDepartment of Obstetrics and Gynaecology, Hemel Hempstead General Hospital, Hemel ...
Twitter Google Share on Facebook (redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
Hereditary resistance to the anticoagulatory action of activated protein C (APC resistance, APCR) was identified as a possible new thrombophilic factor in
The incidence of deep vein thrombosis (DVT) in individuals with heterozygous Factor V Leiden mutation is low. However, DVT risk may be substantially increased when accompanied by nephrotic syndrome. Anticoagulation remains the mainstay of therapy but intervention may be necessary in clinically severe ...
Recurrent venous thromboembolism in a patient with heterozygous factor v leiden mutation. Hosp Pharm, 2014, 49(8): 748-751. 22 Sueta D, Ito M, Uchiba M, et al. A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan-- usefulness of next generation sequencing. ...
The patient’s family history was significant for a mother with deep vein thrombosis (homozygous FVL), and a sister and a maternal cousin with heterozygous factor V Leiden. Histopathologic examination of the evacuated products of conception from her last pregnancy showed hydropic changes with ...
3. De Stefano Ⅴ, Martinelli I, Leone G, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factorⅤ Leiden and the G20210A prothrombin mutation [J]. N Engl J Med, 1999, 341(11):801-806.
bIncludes heterozygous and homozygous individuals. utilization, also consistent with this hypothesis.22,23 However, an evolutionary survival benefit of Factor V Leiden has not been confirmed. DIAGNOSIS Clinical diagnosis No clinical features are specific for Factor V Leiden throm- bophilia. The ...
We report here the evolution of the thrombin generation profile while taking combined oral contraceptives and after their discontinuation in a woman with heterozygous factor V Leiden mutation. The proband exhibited a distinctly prothrombotic thrombin generation profile including markedly decreased thrombomodulin...
Fibrin clot properties in women heterozygous for factor V Leiden mutation: Effects of oral contraceptives Oral contraceptives (OC) in the presence of factor V Leiden mutation (FVL) markedly increase the risk of venous thromboembolism (VTE). Little is known abou... M Krzek,M Ciesla-Dul,M Zab...